Graft-derived macrophage migration inhibitory factor correlates with hepatocellular injury in patients undergoing liver transplantation.
Joanna Baron-StefaniakJudith SchieferEdmund J MillerWalter PlöchlClaus G KrennGabriela A BerlakovichDavid M BaronPeter FaybikPublished in: Clinical transplantation (2017)
Human liver grafts release MIF in proportion to hepatocellular injury. Greater MIF concentrations in effluent and recipient's serum are associated with EAD after liver transplantation.